Search entire site
This page contains information for general practitioners on how to refer patients aged 16 years and over to Gynaecology services at Mater Hospital Brisbane.
Catchment criteria applies for referrals for this service. Patient referrals from outside the Mater SEQ Catchment (which includes Metro South and West Moreton Hospital and Health Services) may not be accepted.
The Gynaecology Service offers a comprehensive individualised approach to patient care. The multidisciplinary team consists of medical specialists, case managers and clinical nurses with access to allied health services including physiotherapy, psychology, social work, occupational therapy and dietetics.
The Gynaecology service also offers specialised services for young adults aged 16 - 25 years at the Mater Young Adult Health Centre Brisbane. These clinics offers a number of clinical services and programs that have been developed with young people in mind.
Other specialised clinics include
How to send a referral
Essential information (Referral will be declined without this) General referral information History of any abnormal bleeding (i.e. post-coital and intermenstrual) or abnormal discharge previous abnormal cervical screening immunosuppressive therapy Medical management to date Most recent and current cervical screening (LBC should be performed on any sample with positive oncogenic HPV) Additional referral information (useful for processing the referral) BMI HPV vaccination history STI screen result endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA History of smoking Other useful information for management (not an exhaustive list) Refer to Healthpathways or local guidelines Women who are in follow-up for pLSIL / LSIL in cytology in the previous program (pre-renewal NCSP) should have a HPV test at their next scheduled follow-up appointment If oncogenic HPV is not detected, the women can return to 5-yearly screening If any HPV is detected, the woman should be referred for colposcopic assessment A single cervical screening test may be considered for women between the ages of 20 and 24 years who experience their first sexual activity at a young age (e.g. before 14 years) who have not recieved the HPV vaccine before sexual activity commenced Adolescent patients with abnormal HPV should follow the same pathway as adult patients. Patients <25 years old should also have screening for STI as they are a high-risk group. Consider using oestrogen cream +/- liquid cytology in post-menopausal women Patients with positive non-16/18 but normal or LSIL on LBC would not need referral and only a repeat CST in 12 months Recall women in 6-12 weeks if they have an unsatisfactory screening report Specific efforts should be made to provide screening for Aboriginal and Torres Strait Islander women. They should be invited and encouraged to participate in the NCSP and have a 5-yearly HPV test, as recommended for all Australian women Women who have been treated for HSIL (CIN2/3) do not need a post-treatment colposcopy. These women should have a co-test (HPV and LBC test) performed at 12 months after treatment, and annually thereafter, until she receives a negative co-test on two consecutive occasions, when she can return to routine 5 yearly screening. This is called ‘test of cure’. If, at any time post treatment, the woman has a positive oncogenic HPV (16/18) test result, she should be referred for colposcopic assessment (regardless of the reflex LBC result). If, at any time during Test of Cure, the woman has a LBC prediction of pHSIL/HSIL or any glandular abnormality, irrespective of HPV status, she should be referred for colposcopic assessment. Clinical resources National Cervical Screening Program: Guidelines for the management of Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Essential information (Referral will be declined without this)
Additional referral information (useful for processing the referral)
Other useful information for management (not an exhaustive list)
Categorisation
Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Category 1 – Urgent
Clinically recommended timeframe for initial appointment is 30 days
Category 2 - Priority
Clinically recommended timeframe for initial appointment is 90 days
Category 3 - Routine
Clinically recommended timeframe for initial appointment is 365 days
Invasive Cancer (SCC, glandular, other). For optimum care, patient should be seen by gynaecological oncology within 2 weeks.
LBC of PHSIL / HSIL
AIS or possible high grade glandular lesion
Positive HPV 16/18 and
Positive HPV non-16/18 and
No category 3 criteria
Essential information (Referral will be declined without this) General referral information Findings of speculum examination Current cervical screening Pelvic USS (TVS preferable) Additional referral information (useful for processing the referral) BMI HRT use Other useful information for management (not an exhaustive list) Small endocervical polyps (<2cm) in premenopausal women with normal cervical screening can be avulsed and sent for histology Cervical polyps in post-menopausal women have a higher risk of malignancy Refer to Healthpathways or local guidelines Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
SCC, positive oncogenic HPV and/or HSIL on LBC, glandular lesion on cervical screening
Cervical polyps in post-menopausal women with normal cervical screening
Cervical polyps in pre-menopausal women with normal cervical screening
Essential information (Referral will be declined without this) General referral information History of: nature of the pain – location, intermittent or persistent general body muscle tensing and general or focal pelvic floor muscle tension before and during attempts at penetration medical, surgical and obstetric history Pelvic USS results (TVS preferable) Additional referral information (useful for processing the referral) BMI STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA HVS M/C/S and viral PCR result Previous CST result (if within last 5 years) Other useful information for management (not an exhaustive list) Advise using lubricant and adequate foreplay prior to intercourse Refer to Healthpathways or local guidelines. For superficial dyspareunia: (consider referral to women’s health physiotherapist) breast feeding women – consider topical oestrogen consider vaginismus and referral to a sexual medicine service consider psychosocial issues and referral for counselling Clinical resources Sexual health services in Queensland Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
No category 1 criteria
Severe pelvic pain associated with dyspareunia
Unexplained persistent unusual vaginal discharge, especially if offensive and blood stained
Vulvodynia/Vulvar vestibulitis syndrome
Essential information (Referral will be declined without this) General referral information History of: symptoms Heavy menstrual Bleeding (HMB), brief description of periods, medical management to date dragging sensation urinary frequency Most recent or current cervical screening FBC iron studies results Pelvic USS (TVS preferable) Additional referral information (useful for processing the referral) BMI Other useful information for management (not an exhaustive list) If asymptomatic (e.g normal menstrual pattern, normal Hb, post menopausal) there is no need for referral Refer to Healthpathways or local guidelines Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Suspicion of degeneration or malignancy
Urinary obstruction, renal impairment e.g. hydroneprhosis, history of urinary retention
Heavy Menstrual Bleeding (HMB) with anaemia (Hb<85) or requiring transfusion
Fibroid prolapse through cervix
Pressure symptoms (such are ureteric impingement)
HMB with anaemia (Hb>85)
Abdominal discomfort
HMB without anaemia not responding to maximal medical management
Fibroids and reproductive issues
Essential information (Referral will be declined without this) General referral information Brief description of periods Medical management to date Current cervical screening FBC Serum ferritin results Pelvic USS (TVS preferable) Adolescent patient - Coag profile including von Willebrand's disease (vWD) Additional referral information (useful for processing the referral) BMI TSH if symptomatic of thyroid disease Previous management modalities, iron utilisation if deficient. Other useful information for management (not an exhaustive list) A woman with heavy menstrual bleeding is referred for early specialist review when there is a suspicion of malignancy or other significant pathology based on clinical assessment or ultrasound. Link: https://www.safetyandquality.gov.au/our-work/clinical-care-standards/heavy-menstrual-bleeding/ Consider increased risk of hyperplasia or malignancy if: Endometrial thickness greater than 12mm (transvaginal USS ideally day 4-7) Irregular endometrium or focal lesion Weight >90kg PCOS / diabetes / unopposed oestrogen Age >45yrs Intermenstrual or post-coital bleeding Medical treatment prior to or while waiting for specialist review if no suspicion of malignancy: Progesterone releasing IUD Tranexamic acid OCP NSAIDS Oral progestogens Referral is also arranged for a woman who has not responded after six months of medical treatment. Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Medical treatment prior to or while waiting for specialist review if no suspicion of malignancy:
Referral is also arranged for a woman who has not responded after six months of medical treatment.
Suspicion of malignancy
HMB with anaemia (Hb<85)
HMB without anaemia not responding to medical management
Essential information (Referral will be declined without this) General referral information History of: previous pregnancies, STIs and PID, surgery, endometriosis other medical conditions Include the following information about partner age and health, reproductive history, testicular conditions, semen analysis Weight/ BMI STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA FBC group and antibodies rubella IgG varicella IgG, syphillis serology, HBV/HCV/HIV serology results FSH, LH (Day 2-5), prolactin, TSH if cycle prolonged and/or irregular Anti-mullerian hormone (AMH) Pelvic USS (TVS preferable) If PCOS is suspected include the following: Free androgen index (FAI) or Free Testosterone Fasting blood glucose result Lipids, TSH results Infertility – additional Essential Referral Information Day 21 serum progesterone level (7 days before the next expected period) First trimester RPL – additional Essential Referral Information Thrombophilia screen, antiphospholipid syndrome (APS) Autoimmune screen Coeliac serology – serum deamidated gliadin peptide (DGP), tTG Ab Antinuclear antibodies (ANA) only if personal or family history indicates higher risk of autoimmune disease Karyotype for both parents Second trimester RPL – additional Essential Referral Information Hysterosalpingogram (HSG) or hystero-sonogram US with cervical length
Second trimester RPL – additional Essential Referral Information
Other useful information for management (not an exhaustive list) IVF not available in Mater public hospitals Refer to HealthPathways and or local guidelines Treatment is as a couple and requires a partner referral To assess tubal patency, consider Hysterosalpingography (HSG) or saline infusion USS (sonohysterography) if history suggestive of blocked fallopian tubes Seminal analysis of partner (≥4 days of abstinence). Repeat in 4-6 weeks if abnormal. Lifestyle modification (increased activity, dietary, weight, smoking, alcohol) simple moderate physical activity including structured exercise (at least 30 minutes/day) and optimising incidental exercise with weight loss and weight maintenance achieve optimal weight BMI 20 – 30 referral to dietician Infertility: folic Acid 0.5mg/day RPL: Definition ≥ Three (3) CONSECUTIVE miscarriages (excluding chemical miscarriages) as documented by ultrasonography or histopathologic examination. Second trimester miscarriages are considered more significant. Two (2) would be an indication for further investigation. Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Reproductive counselling for fertility sparing options prior to cancer treatment including surgery and chemotherapy
All other category 1 referrals for interfility are not accepted, refer to a private specialist to avoid delay
Category 2 referral for infertility are not accepted, refer to a private specialist to avoid delay
All referrals for infertility for example but not limited to
(Definition - Infertility is the failure to achieve pregnancy after 12 months or more of unprotected intercourse
Essential information (Referral will be declined without this) General referral information History of abnormal bleeding / hormonal contraceptive use Recent co-test result (HPV and LBC) HVS result BHCG result STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA Pelvic USS (TVS preferable) Additional referral information (useful for processing the referral) BMI Other useful information for management (not an exhaustive list) Refer to local Healthpathways or local guidelines Reference material - RANZCOG, Investigation of intermenstrual and post coital bleeding Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Oncogenic HPV, LBC prediction of pHSIL/HSIL, possible high-grade glandular lesion, AIS, or invasive cancer - cervical or endometrial
Focal endometrial lesion
IMB not due to hormonal contraception
Abnormal cervical screening )(other than for Cat 1)
Endometrium >12mm / irregular on pelvic USS (TVS ideally day 5-10)
Persistent and/or unexplained IMB
IMB bleeding related to hormonal contraception that is not responding to medical management e.g. contraception manipulation
Essential information (Referral will be declined without this) General referral information Medical management to date/surgical history History of pain and menstrual diary Symptoms dysmenorrhoea deep dyspareunia dyschezia history of sub-fertility Pelvic USS results (TVS preferable) if available Additional referral information (useful for processing the referral) BMI Menstrual diary (if available) Other useful information for management (not an exhaustive list) Refer to Healthpathways or local guidelines Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Multiple emergency presentations
Endometriomas on USS
Endometriosis/chronic not responding to maximal medical management
Associated bowel or bladder disturbance
Endometriosis and reproductive issues
Essential information (Referral will be declined without this) General referral information Medical history - relevant family, menstrual, obstetric, contraceptive, and brief sexual history or history of STDS Most recent or current cervical screening Mirena® prescription – at Mater Hospital the referring GP does not need to provide a prescription for the device, nor is the patient required to bring the device with her to the clinic. The gynaecology clinic stocks and supplies Mirena devices according to usual PBS arrangements. Additional referral information (useful for processing the referral) BMI Pelvic USS if lost strings, HMB or other clinical indication STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA Other useful information for management (not an exhaustive list) Mirena® prescription to be supplied by referring GP. Patient must bring the device with her to the clinic For paediatric and adolescent gynaecology patients please refer to statewide paediatric and adolescent gynaecology (SPAG) services at Queensland Children's Hospital/RBWH Where available for the routine removal or insertion of Mirena®/progesterone releasing IUD please consider referral to True – relationships and reproductive health (formerly known as Family Planning Queensland) or a Women’s Health speciality primary care provider who may be able to provide this service in their own clinic. Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
HMB with anaemia (Hb<85) or requiring transfusion
Contraception (if clinically indicated)
HRT
Replacement Mirena/Progesterone releasing IUD (if clinically indicated)
Mirena/Progesterone releasing IUD insertion or removal (if clinically indicated)
NB: Routine Mirena®/progesterone-releasing IUD insertion for contraception are out-of-scope for Gynaecology at Mater Health services.
Essential information (Referral will be declined without this) General referral information History including pain and other symptoms CA125 results Pelvic USS (TVS preferable) Additional referral information (useful for processing the referral) BMI Family history of breast and ovarian cancer ROMA score in premenopausal women with elevated CA125 In paediatric and adolescent patients, remember to exclude germ cell tumours with markers: alpha feto protein LDH BHCG along with the other tumour markers Other useful information for management (not an exhaustive list) Refer to Healthpathways or local guidelines ROMA score in premenopausal women with elevated CA125 would be beneficial to have at the time of the referral. However, this may incur an out-of-pocket cost to the patient. If cyst simple or haemorrhagic corpus luteal cyst and <5 cm repeat scan in 6 – 12 weeks If recurrent cysts, consider COCP or Implanon® Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Suspicious of malignancy or high risk features:
Consider if significant pain and/or due to risk of torsion
Pre-pubertal patient
Persistent ovarian cyst >5cm on 2 pelvic USS 6 weeks apart
Complex cyst (haemorrhagic, endometriotic or dermoid)
Persistent pelvic pain
Hydrosalpinx
Essential information (Referral will be declined without this) General referral information Obstetric and gynaecological history History of: prolapse symptoms protruding lump dragging sensation difficulty with defecation (requiring manual evacuation) / micturition including incontinence MSU M/C/S results Additional referral information (useful for processing the referral) BMI Previous failed or complicated prolapse surgery Pelvic USS (TVS preferable) if available Bladder diary Renal USS if major uterine procidenta Other useful information for management (not an exhaustive list) Refer to HealthPathways and or local guidelines Patients with chronic pelvic pain following mesh procedures can be referred to the Queensland Pelvic Mesh Service (QPMS) for assessment This service offers comprehensive, interdisciplinary assessment and treatment for women with complications from pelvic mesh. Further information is available on the Qld Health website Queensland Pelvic Mesh Service (QPMS) website Clinical resources QPMS Referral form Patient resources Consider referral to women’s health physiotherapist for the following: prolapse – consider pessary stress incontinence – physiotherapist for pelvic floor exercises and bladder retraining for 3 months prior to referral urinary urgency - exclude infection Consider trial of anticholinergics Treat constipation Consider topical oestrogen in post-menopausal women Lifestyle modification (Increased activity, dietary, weight, smoking, alcohol) Mesh removal in Australia Qld Health website Urogynaecologist society of Australasia – Patient information The ACSQHC information on stress urinary incontinence and pelvic organ prolapse Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Uterine procidentia
Difficulty voiding with renal impairment
Difficulty voiding +/- significant residuals on bladder screening (without renal impairment)
Recurrent UTIs
Genital fistulae
Mesh erosion or bleeding/pain
Any other prolapse or incontinence
Obstructive defecation
Essential information (Referral will be declined without this) General referral information History of/to: pain, severity and duration, cyclical nature, dysmenorrhoea differentiate from GI pain previous sexual abuse, PID medical management to date Most recent or current cervical screening HVS result STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA MSU M/C/S result Pelvic USS (TVS preferable) if available Additional referral information (useful for processing the referral) BMI Other useful information for management (not an exhaustive list) Refer to local Healthpathways or local guidelines Medical management Important to exclude cyclical bladder, bowel symptoms Treat infection if present Simple analgesia Suppress menstrual cycle with oral contraceptive pill / implanon® / depo-provera / mirena® Treat dysmenorrhoea with NSAIDS or COCP Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Medical management
Pelvic pain and significant USS findings e.g. presence of endometriomas / fixed retroverted uterus
Chronic pain not responding to maximal medical management
Essential information (Referral will be declined without this) General referral information Pelvic ultrasound (incl. TVS) Day 21 Progesterone (D21P) SHBG results Free Testosterone (FAI), DHEA-S results Fasting blood glucose results Lipids, TSH results If problems with sub fertility: History of previous pregnancies, STDs and PID, surgery, endometriosis other medical conditions Include the following information about partner age and health, reproductive history, testicular conditions Weight/ BMI FBC Group and antibodies Rubella IgG Varicella IgG, Syphilis Serology, HBV/HCV/HIV serology results Day 21 serum progesterone level (7 days before the next expected period) FSH, LH (Day 2-5), Prolactin, TSH if cycle prolonged and/or irregular STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA Partner semen analysis result Pelvic USS (TVS preferable on day 5-10) Additional referral information (useful for processing the referral) Ensure BMI sent as essential information above Other useful information for management (not an exhaustive list) Psychological features need to be screened for, acknowledged, discussed and counselling considered, to improve quality of life in PCOS and to facilitate effective and sustainable lifestyle change consideration of depression and/or anxiety and appropriate management Emphasis on healthy lifestyle, with targeted medical therapy where indicated Lifestyle modification (increased activity, dietary, weight, smoking, alcohol) simple moderate physical activity including structured exercise (at least 30 minutes/day) and optimising incidental exercise assists with weight loss and weight maintenance achieve optimal weight BMI 20 – 30 referral to dietician Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
If problems with sub fertility:
Category 1 – urgent
Abnormal endometrium on ultrasound (i.e. irregular / focal lesion or thickened – over 12mm)
No category 2 criteria
Polycystic ovarian syndrome as per Rotterdam criteria
Diagnostic criteria for Rotterdam diagnosis of polycystic ovary syndrome Two of the following three criteria are required:
Essential information (Referral will be declined without this) General referral information Findings of speculum examination Recent co-test result (HPV and LBC) HVS result Sexual health history STI screen result - endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA Additional referral information (useful for processing the referral) BMI Pelvic USS (TVS preferable) Contraceptive use Other useful information for management (not an exhaustive list) Refer to local Healthpathways or local guidelines Pre-menopausal women who have a single episode of post-coital bleeding and a clinically normal cervix do not need to be reported if oncogenic HPV is not detected and LBC is negative Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Suspected malignancy
Post-coital bleeding recurs or persists despite negative HPV or LBC
Essential information (Referral will be declined without this) General referral information History of HRT use Recent co-test result (HPV and LBC) Pelvic USS (TVS preferable) Additional referral information (useful for processing the referral) BMI Other useful information for management (not an exhaustive list) Refer to local Healthpathways or local guidelines Postmenopausal women with an incidental finding on pelvic ultrasound of a regular endometrial thickness of less than 11mm and having no episodes of postmenopausal bleeding would only need a repeat ultrasound and referral if developing vaginal bleeding Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Endometrial thickness >4mm
Cervical polyps
Endometrial thickness ≤4mm
Essential information (Referral will be declined without this) General referral information Duration of amenorrhoea (i.e. >6 months) Weight/ BMI BHCG results FSH LH prolactin oestradiol TSH results TAS-TVS USS may not be appropriate in non-sexually active females, therefore important to seek early advice from statewide paediatric and adolescent gynaecology (SPAG) services Additional referral information (useful for processing the referral) BMI Renal USS Other useful information for management (not an exhaustive list) Primary amenorrhoea – is defined as the absence of menses at age 16 years in the presence of normal growth and secondary sexual characteristics and 14 in the absence of secondary sexual characteristics Secondary amenorrhoea – absence of menses for more than six months after the onset of menses Refer to statewide paediatric and adolescent gynaecology (SPAG) services at Queensland Children's Hospital/RBWH Address excessive exercise or dieting If BMI is greater than 30, manage weight loss Address any significant stress or anxiety Review medications if relevant (e.g. antipsychotics, metoclopramide) Cyclical abdominal pain in adolescent with primary amenorrhoea might be indication of imperforate hymen Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Primary amenorrhoea
Secondary amenorrhoea
Essential information (Referral will be declined without this) General referral information History of: Pain, swelling pruritus dyspareunia localised lesions (pigmented or non-pigmented lesions) STIs or other vaginal infections local trauma Elicit onset, duration and course of presenting symptoms Date of last menstrual period Medical management to date Cervical screening if referral for warts Additional referral information (useful for processing the referral) BMI Vulva ulcers – swab M/C/S and viral PCR result Vulval rashes – scraping, swaps or biopsy (as appropriate) STI screen result -endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA (as appropriate) Syphillis HIV serology (as appropriate) Other useful information for management (not an exhaustive list) For or paediatric and adolescent gynaecology patients, please refer to statewide paediatric and adolescent gynaecology (SPAG) services at Queensland Children's Hospital/RBWH <14 years refer to Queensland Children's Hospital >14 years refer to RBWH or local adolescent gyane service Antibiotic treatment of Bartholins cyst is of no value. In women where a vulval cancer is strongly suspected on examination, urgent referral should not await biopsy Vulval cancers may present as unexplained lumps, bleeding from ulceration or pain. Vulval cancer may also present with pruritus or pain. For a patient who presents with these symptoms and where cancer is not immediately suspected, it is reasonable to use a period of ‘treat, watch and wait’ as a method of management. However, this should include active follow-up until symptoms resolve or a diagnosis is confirmed. If symptoms persist, the referral may be urgent or non-urgent, depending on the symptoms and the degree of concern about cancer. Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Vulval disease with suspicion of malignancy. For optimum care, patient should be seen within 2 weeks.
Unexplained vulval lump, ulceration or bleeding. For optimum care, patient should be seen within 2 weeks.
Postmenopausal women with abnormal vulval lesions
Pregnant or immunosuppressed
Suspected vulval dystrophy
Bartholin’s cysts or other vulval cysts in patients >40 years old
Vulval warts where:
Vulval lesion where:
Vulval rashes
Vulval warts
Bartholin’s cyst/labial cysts
Essential information (Referral will be declined without this) General referral information Confirmation that the Implanon is insitu Ultrasound +/- X-ray prior to referral Additional referral information (useful for processing the referral) No additional referral information Other useful information for management (not an exhaustive list) Refer to local Healthpathways or local guidelines In some facilities, the referral maybe referred to the Medical Imaging Department where the procedure is performed under ultrasound guidance (or alternative imaging) by interventional radiologist or this can be managed in True clinic (with experienced practitioners removing deep but palpable implants) Non-palpable implant should be located. If palpation of the Implanon implant is not successful, an ultrasound may be arranged for definitive localisation. MRI, X-ray, and CT scan provide further tools for implant localisation. Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Essential information (Referral will be declined without this) General referral information Relevant condition information Relevant pathology and imaging reports Categorisation Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.
Contact Us
If you would like to discuss a referral, including clinical criteria, or update the status of a current patient please contact our priority GP phone line on 07 3163 2200
We provide up to date data on how long patients are waiting for their first appointment by specialtly here.
These Mater Referral Guidelines align with standardised best practice tools for referral to publicly funded specialist outpatient services developed in Queensland through the Clinical Prioritisation Criteria project.
Content last reviewed: 13 December 2023
Search for a private Mater specialist to see your patient.
Read more
GP Education, Maternity Shared Care Alignment Program and Events.
GP Maternity Shared Care Alignment - Seminar 2